Patents by Inventor Dulce Soler-Ferran

Dulce Soler-Ferran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD21 ANTIBODIES AND USES THEREOF
    Publication number: 20240376225
    Abstract: Provided herein are anti-CD21 antibodies or antigen binding fragments thereof and their use in the treatment of autoimmune diseases or disorders.
    Type: Application
    Filed: July 6, 2022
    Publication date: November 14, 2024
    Applicants: The Children's Medical Center Corporation, PFIZER INC.
    Inventors: Hulian GAO, Michael C. CARROLL, Oleg Victorovich KOVALENKO, Eric Matthew BENNETT, Janet Elizabeth BUHLMANN, Xianchun TANG, Stefano Vincenzo GULLA, Nathan HIGGINSON-SCOTT, Fridrik Jensen KARLSSON, Dulce SOLER-FERRAN, Jessica Haewon MIN DEBARTOLO
  • Method for identifying agents which modulate chemokine "MEC"-induced functions of CCR3 and/or CCR10
    Publication number: 20020137107
    Abstract: The invention relates to the interaction of MEC with CCR3 and/or CCR10 and to agents (e.g., ligands, antibodies, antagonists, agonists, inhibitors, promoters) which alter said interaction. In one aspect, the invention relates to methods for detecting or identifying an agent (i.e., molecule or compound) which can modulate (inhibit, promote) the binding of MEC to CCR3 and/or CCR10. In another aspect, the invention relates to a method of treating a subject having an inflammatory condition, comprising administering to the subject an effective amount of an agent which modulates the binding of MEC to CCR3 and/or CCR10.
    Type: Application
    Filed: August 15, 2001
    Publication date: September 26, 2002
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Eugene C. Butcher, Eric J. Kunkel, Junliang Pan, Dulce Soler-Ferran